Global X Genomics & Biotechnology UCITS ETF (ETR:GN0M)

Assets	111.41M
Expense Ratio	0.50%
PE Ratio	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+89.81%

Volume	58,691
Open	10.55
Previous Close	10.51
Day's Range	10.50 - 10.84
52-Week Low	5.60
52-Week High	10.84
Beta	n/a
Holdings	52
Inception Date	Nov 2, 2021

About GN0M

GNOM.L was created on 2021-11-02 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Funds investment objective is to generate returns that closelyrncorrespond, before fees and expenses, generally to the price and yieldrnperformance of the Solactive Genomics v2 Index

• Asset Class: Equity
• Category: Theme
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: GN0M
• Provider: Global X
• Index Tracked: Solactive Genomics v2 Index - Benchmark TR Net

Performance

GN0M had a total return of 89.81% in the past year, including dividends. Since the fund's inception, the average annual return has been -4.12%.

Top 10 Holdings

52.64% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	7.98%
Twist Bioscience Corporation	TWST	7.39%
10x Genomics, Inc.	TXG	6.53%
Guardant Health, Inc.	GH	5.76%
Illumina, Inc.	ILMN	5.27%
Natera, Inc.	NTRA	5.12%
Genscript Biotech Corporation	1548	4.29%
Bio-Techne Corporation	TECH	3.55%
BioMarin Pharmaceutical Inc.	BMRN	3.40%
Vertex Pharmaceuticals Incorporated	VRTX	3.35%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error